Y. Yu, J.-D. Zhao, H. Yang

Perinatal Care Division, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, P.R. China

The article “MiR-299-3p inhibits proliferation and invasion of cervical cancer cell via targeting TCF4” by Y. Yu, J.-D. Zhao, H. Yang published in Eur Rev Med Pharmacol Sci 2019; 23 (13): 5621-5627–DOI: 10.26355/eurrev_201907_18296–PMID: 31298314 has been retracted by the Editor in Chief.

Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/4275612B2FA-7C9A9CD7255B791D3A6), the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation.

The journal’s investigation revealed data fabrication and several figure manipulations. Specifically, duplications were found within Figures 2C, 2F, 3C, 4A, and 4E. Moreover, Figure 2 (C, D, E), Figure 3C, and Figure 4 (C-D) contained duplications from previously published articles.

The authors have been informed about the journal’s investigation but remained unresponsive and have not provided the study’s raw data.

Consequently, the Editor in Chief decided to retract the article.

This article has been retracted. The Publisher apologizes for any inconvenience this may cause.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

Y. Yu, J.-D. Zhao, H. Yang
Retraction Note: MiR-299-3p inhibits proliferation and invasion of cervical cancer cell via targeting TCF4

Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 21
Pages: 4490-4490
DOI: 10.26355/eurrev_202411_36905